First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a large decrease in short interest in February. As of February 15th, there was short interest totalling 700 shares, a decrease of 41.7% from the January 31st total of 1,200 shares. Based on an average daily trading volume, of 2,800 shares, the short-interest ratio is presently 0.3 days.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

A number of institutional investors have recently bought and sold shares of the stock. Vivaldi Capital Management LP increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 15.6% during the 4th quarter. Vivaldi Capital Management LP now owns 8,677 shares of the company’s stock valued at $243,000 after purchasing an additional 1,171 shares in the last quarter. Summit Investment Advisors Inc. lifted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 13.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 14,173 shares of the company’s stock worth $382,000 after buying an additional 1,633 shares during the period. Envestnet Asset Management Inc. grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 17.0% during the fourth quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock valued at $442,000 after buying an additional 2,384 shares during the last quarter. Finally, LPL Financial LLC increased its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 9.3% in the 4th quarter. LPL Financial LLC now owns 55,876 shares of the company’s stock valued at $1,507,000 after acquiring an additional 4,776 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

First Trust Nasdaq Pharmaceuticals ETF stock traded up $0.25 during midday trading on Friday, reaching $28.11. The company’s stock had a trading volume of 1,888 shares, compared to its average volume of 3,254. The stock has a market capitalization of $14.06 million, a P/E ratio of 15.98 and a beta of 0.70. The stock’s 50-day simple moving average is $27.41 and its 200-day simple moving average is $28.13. First Trust Nasdaq Pharmaceuticals ETF has a 52-week low of $25.73 and a 52-week high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th were issued a dividend of $0.1304 per share. The ex-dividend date was Friday, December 13th. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.